TuisALM • VIE
add
Almirall SA
Vorige sluiting
€12,72
Dagwisseling
€12,76 - €12,80
Jaarwisseling
€8,09 - €12,88
Markkapitalisasie
2,75 mjd EUR
Gemiddelde volume
4,00
P/V-verhouding
92,25
Dividend-opbrengs
1,44%
Primêre beurs
BME
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 262,23 m | 13,46% |
Bedryfskoste | 81,32 m | -10,39% |
Netto inkomste | 12,52 m | 252,88% |
Netto winsgrens | 4,77 | 234,75% |
Wins per aandeel | — | — |
EBITDA | 69,66 m | 54,14% |
Effektiewe belastingkoers | 40,30% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 376,60 m | 9,76% |
Totale bates | 2,36 mjd | 2,22% |
Totale aanspreeklikheid | 882,40 m | 5,15% |
Totale ekwiteit | 1,48 mjd | — |
Uitstaande aandele | 214,79 m | — |
Prys om te bespreek | 1,85 | — |
Opbrengs op bates | 2,48% | — |
Opbrengs op kapitaal | 3,16% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 12,52 m | 252,88% |
Kontant van bedrywe | 88,75 m | 123,07% |
Kontant van beleggings | -26,17 m | -176,24% |
Kontant van finansiering | -8,93 m | 13,87% |
Netto kontantverandering | 53,65 m | -15,83% |
Beskikbare kontantvloei | 98,14 m | -21,84% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
2 084
